Corynebacterium parvum versus bacille calmette-guérin adjuvant immunotherapy of stage II malignant melanoma

Allan Lipton, Harold A. Harvey, Charles M. Balch, Charles E. Antle, Robert Heckard, Alfred A. Bartolucci

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Corynebacterium parvum versus bacille calmette-guérin adjuvant immunotherapy of stage II malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences